Clinical Trials on Left-Sided Breast Cancer in Belgium

Total 457 results

Ethicon Endo-Surgery

Completed

A Prospective, Multi-Center Evaluation of the ECHELON CIRCULAR Powered Stapler in Left-Sided Colorectal Anastomoses (EPMCS-CA)

Left-sided Colon Resection

United States, United Kingdom, Belgium, Germany, Spain
Restore Medical Ltd

Recruiting

ContraBand™: FIH Safety & Feasibility Study (RM-20-01)

Heart Failure, Left Sided

Belgium, Lithuania, Georgia, Israel, Poland
Abbott Medical Devices

Completed

CardioMEMS HF System OUS Post Market Study

Heart Failure | Congestive Heart Failure | Left-Sided Heart Failure

France, Denmark, Australia, Belgium, United Kingdom
Jules Bordet Institute

Completed

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)

Metastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast Cancers

Belgium
Jules Bordet Institute

Recruiting

PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer. (PRISMA)

TNBC - Triple-Negative Breast Cancer

Belgium
Universitair Ziekenhuis Brussel
eTheRNA immunotherapies

Recruiting

Intratumoral TriMix Injections in Early Breast Cancer Patients (TMBA)

Breast Cancer Female | Early-stage Breast Cancer

Belgium
Jules Bordet Institute

Completed

ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue. (EC2075)

Breast Cancer.

Belgium
Jules Bordet Institute

Completed

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

Invasive Breast Cancer

Belgium
XEOS Medical

Recruiting

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer (BrIMA)

Breast Cancer | Breast Cancer Invasive | Breast Cancer in Situ

Belgium
Jules Bordet Institute
KU Leuven; University of Milan

Not yet recruiting

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) (KePreSt)

Early-stage Breast Cancer | Estrogen-receptor-positive Breast Cancer

Belgium
Pierre Fabre Medicament
Iqvia Pty Ltd

Recruiting

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib (NEAR)

Breast Cancer | HER2-positive Breast Cancer | Adjuvant Therapy

Belgium
Universitair Ziekenhuis Brussel
Hopital Antoine Beclere

Recruiting

Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer (Coimbra)

Breast Cancer Female

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Neoplasm

Belgium
University Hospital, Ghent

Recruiting

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Breast Neoplasms | Breast Cancer Female

Belgium
KU Leuven
Novartis

Unknown

Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer (IPSOC-mamma)

ER Positive, HER2 Negative Breast Cancer Neoplasms

Belgium
Jules Bordet Institute

Unknown

Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer

Breast Cancer | Metastatic Cancer

Belgium
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
Jules Bordet Institute

Completed

Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA) (NeoRHEA)

Breast Cancer Female

Belgium
Modra Pharmaceuticals

Completed

ModraDoc006/r in Patients With Breast Cancer

Metastatic Breast Cancer | Recurrent Breast Cancer

Denmark, Belgium, Spain
Jessa Hospital
Hasselt University

Recruiting

Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema (LymphLight)

Breast Cancer | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema

Belgium
Universitair Ziekenhuis Brussel
Universitaire Ziekenhuizen KU Leuven

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female

Belgium
University Hospital, Ghent

Recruiting

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema (LVARCT)

Lymphedema, Breast Cancer

Belgium
University of Liege
CHU of Liège; Fonds pour la Recherche Scientifique (FRS-FNRS)

Recruiting

Psychoneurological Symptom Cluster in Oncology

Cancer | Breast Cancer | Digestive Cancer

Belgium
University of Liege

Completed

Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being (GIBC)

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer (IMAGE)

Breast Cancer

Belgium
Jules Bordet Institute
Centre Hospitalier Universitaire de Tivoli; Hôpital de Braine-l'Alleud; Clinique... and other collaborators

Completed

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Breast Cancer

Belgium
University Hospital, Ghent

Not yet recruiting

FAST-FORWARD vs HAI5

Cancer, Breast

Belgium
Cliniques universitaires Saint-Luc- Université...
Jules Bordet Institute

Recruiting

A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors (CICLIBIOME)

Breast Cancer

Belgium
KU Leuven
Universitaire Ziekenhuizen KU Leuven; Vrije Universiteit Brussel

Recruiting

Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity (UPLIFT-BC)

Breast Cancer

Belgium
KU Leuven
Universitaire Ziekenhuizen KU Leuven; Vrije Universiteit Brussel

Recruiting

Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment (UPLIFT-BC)

Breast Cancer

Belgium
Brugmann University Hospital

Completed

Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study

Breast Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer (Breast-sign)

Breast Cancer

Belgium
Brugmann University Hospital

Withdrawn

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

Breast Cancer

Belgium
Université Libre de Bruxelles
Jules Bordet Institute

Completed

Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment

Breast Cancer

Belgium
Neovii Biotech

Terminated

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer (IV REXBC 02)

Breast Cancer | Breast Neoplasms

Belgium
Universitaire Ziekenhuizen KU Leuven
St-Augustinus Wilrijk

Completed

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk Women

Breast Cancer

Belgium
Jules Bordet Institute

Recruiting

ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study (BREASTIFLU-1)

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)

Breast Cancer

Belgium
Jules Bordet Institute

Completed

Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy

Breast Cancer

Belgium
Jules Bordet Institute

Completed

Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer (EndoTAG-1)

Breast Cancer

Belgium
Stemline Therapeutics, Inc.

Completed

Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer

Metastatic Breast Cancer

Netherlands, Belgium
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

S 81694 Plus Paclitaxel in Metastatic Breast Cancer

Metastatic Breast Cancer | Metastatic Triple Negative Breast Cancer

Japan, Belgium, France, Netherlands
University Hospital, Ghent

Completed

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer (HAI-5)

Breast Cancer | Radiotherapy

Belgium
Pfizer

Terminated

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Early Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)

Spain, Sweden, Italy, Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Magnetic Seed Localisation for Nonpalpable Breast Lesions

Breast Cancer | Oncology

Belgium
Jules Bordet Institute

Withdrawn

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer (RHEA)

Breast Cancer

Belgium, France
Universitaire Ziekenhuizen KU Leuven

Recruiting

Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema (DEARLY)

Breast Cancer | Lymphedema of Upper Arm | Diagnoses Disease

Belgium
Jules Bordet Institute

Completed

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

Breast Cancer | Elderly Patients

Belgium

Clinical Trials on Left-Sided Breast Cancer in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations